CD19 CAR T‐Cell Therapy in Primary Cutaneous Diffuse Large B‐Cell Lymphoma, Leg Type
Authors:
- 30 January 2026
- journal article
- Published by Wiley in American Journal of Hematology
- Vol. 101 (6) , 1167-1172
Abstract
No abstract availableFunding Information
- National Institutes of Health (P30 CA008748)
- National Cancer Institute
- Lymphoma Research Foundation
This publication has 27 references indexed in Scilit:
- Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation studyThe Lancet Oncology, 2024
- Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trialThe Lancet, 2022
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design studyThe Lancet, 2020
- Effectiveness of lenalidomide in relapsed primary cutaneous diffuse large B‐cell lymphoma, leg typeClinical Case Reports, 2019
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trialThe Lancet Oncology, 2019
- A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg TypeJournal of Investigative Dermatology, 2018
- Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive LymphomaMolecular Therapy, 2017
- High Frequency and Clinical Prognostic Value of MYD88 L265P Mutation in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-TypeJAMA Dermatology, 2014
- MYD88 Somatic Mutation Is a Genetic Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg TypeJournal of Investigative Dermatology, 2012
- Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg TypeArchives of Dermatology, 2007